Company Search:
Advanced Search
Sponsored Links
Haw Par Corporation Limited Company Snapshot
Haw Par Corporation Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Haw Par Corporation Limited with three other pharmaceutical manufacturers in Asia: Merck Limited of India (2017 sales of 11.04 billion Indian Rupees [US$169.90 million] ), Koei Chemical Company, Limited of Japan (17.28 billion Japanese Yen [US$162.94 million] ), and Indoco Remedies Ltd which is based in India (10.93 billion Indian Rupees [US$168.23 million] of which 100% was Pharmaceuticals).

Sales Analysis. Haw Par Corporation Limited reported sales of 222.76 million Singapore Dollars (US$169.02 million) for the year ending December of 2017. This represents an increase of 10.5% versus 2016, when the company's sales were 201.64 million Singapore Dollars. Sales at Haw Par Corporation Limited have increased during each of the previous five years (and since 2012, sales have increased a total of 60%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Haw Par Corporation Limited
  Stock Performance Chart for Haw Par Corporation Limited
  Stock Data: Recent Stock Performance:
  Current Price (3/16/2018): 12.61
(Figures in Singapore Dollars)
1 Week 4.0%   13 Weeks 4.0%  
4 Weeks 11.5%   52 Weeks 27.1%  
Haw Par Corporation Limited Key Data:
  Ticker: H02 Country: Singapore
  Exchanges: HKG KUL SIN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 222,763,000
(Year Ending Jan 2018).
Employees: 513
  Currency: Singapore Dollars Market Cap: 2,775,980,192
  Fiscal Yr Ends: December Shares Outstanding: 220,141,173
  Share Type: Ordinary Closely Held Shares: 81,118,637
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.